307 related articles for article (PubMed ID: 8097244)
1. Mu opiate receptor down-regulation by morphine and up-regulation by naloxone in SH-SY5Y human neuroblastoma cells.
Zadina JE; Chang SL; Ge LJ; Kastin AJ
J Pharmacol Exp Ther; 1993 Apr; 265(1):254-62. PubMed ID: 8097244
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of mu and delta opiate receptors by morphine, selective agonists and antagonists and differentiating agents in SH-SY5Y human neuroblastoma cells.
Zadina JE; Harrison LM; Ge LJ; Kastin AJ; Chang SL
J Pharmacol Exp Ther; 1994 Sep; 270(3):1086-96. PubMed ID: 7932156
[TBL] [Abstract][Full Text] [Related]
3. Tyr-W-MIF-1 attenuates down-regulation of opiate receptors in SH-SY5Y human neuroblastoma cells.
Harrison LM; Kastin AJ; Zadina JE
J Pharmacol Exp Ther; 1998 Feb; 284(2):611-7. PubMed ID: 9454805
[TBL] [Abstract][Full Text] [Related]
4. Selective and interactive down-regulation of mu- and delta-opioid receptors in human neuroblastoma SK-N-SH cells.
Baumhaker Y; Gafni M; Keren O; Sarne Y
Mol Pharmacol; 1993 Aug; 44(2):461-7. PubMed ID: 8394999
[TBL] [Abstract][Full Text] [Related]
5. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
[TBL] [Abstract][Full Text] [Related]
6. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
[TBL] [Abstract][Full Text] [Related]
7. Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: a useful model for the study of tolerance at mu opioid receptors.
Puttfarcken PS; Werling LL; Cox BM
Mol Pharmacol; 1988 May; 33(5):520-7. PubMed ID: 2835651
[TBL] [Abstract][Full Text] [Related]
8. Antagonist-induced transient down-regulation of delta-opioid receptors in NG108-15 cells.
Belcheva MM; Barg J; Gloeckner C; Gao XM; Chuang DM; Coscia CJ
Mol Pharmacol; 1992 Sep; 42(3):445-52. PubMed ID: 1328845
[TBL] [Abstract][Full Text] [Related]
9. Ni-coupled receptors in cultured neural hybrid cells: cell specificity for dibutyryl cyclic AMP-induced down-regulation but not morphological differentiation.
Noronha-Blob L; Lowe VC; Kinnier WJ; U'Prichard DC
Mol Pharmacol; 1986 Dec; 30(6):526-36. PubMed ID: 3023808
[TBL] [Abstract][Full Text] [Related]
10. Intact cell binding and the relation to opioid activities in SH-SY5Y cells.
Toll L
J Pharmacol Exp Ther; 1995 May; 273(2):721-7. PubMed ID: 7752076
[TBL] [Abstract][Full Text] [Related]
11. Mu-opioid receptor inhibition of calcium current: development of homologous tolerance in single SH-SY5Y cells after chronic exposure to morphine in vitro.
Kennedy C; Henderson G
Mol Pharmacol; 1991 Dec; 40(6):1000-5. PubMed ID: 1661836
[TBL] [Abstract][Full Text] [Related]
12. [3H]-[H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2] ([3H]CTOP), a potent and highly selective peptide for mu opioid receptors in rat brain.
Hawkins KN; Knapp RJ; Lui GK; Gulya K; Kazmierski W; Wan YP; Pelton JT; Hruby VJ; Yamamura HI
J Pharmacol Exp Ther; 1989 Jan; 248(1):73-80. PubMed ID: 2563293
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase C activation increases the rate and magnitude of agonist-induced delta-opioid receptor down-regulation in NG108-15 cells.
Gucker S; Bidlack JM
Mol Pharmacol; 1992 Oct; 42(4):656-65. PubMed ID: 1331757
[TBL] [Abstract][Full Text] [Related]
14. Morphine desensitization, internalization, and down-regulation of the mu opioid receptor is facilitated by serotonin 5-hydroxytryptamine2A receptor coactivation.
Lopez-Gimenez JF; Vilaró MT; Milligan G
Mol Pharmacol; 2008 Nov; 74(5):1278-91. PubMed ID: 18703670
[TBL] [Abstract][Full Text] [Related]
15. Opioid agonist and antagonist treatment differentially regulates immunoreactive mu-opioid receptors and dynamin-2 in vivo.
Yoburn BC; Purohit V; Patel K; Zhang Q
Eur J Pharmacol; 2004 Sep; 498(1-3):87-96. PubMed ID: 15363980
[TBL] [Abstract][Full Text] [Related]
16. Receptor mechanisms of opioid tolerance in SH-SY5Y human neural cells.
Carter BD; Medzihradsky F
Mol Pharmacol; 1993 Mar; 43(3):465-73. PubMed ID: 8383804
[TBL] [Abstract][Full Text] [Related]
17. H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2: a potent and selective antagonist opioid receptors.
Gulya K; Lui GK; Pelton JT; Kazmierski W; Hruby VJ; Yamamura HI
NIDA Res Monogr; 1986; 75():209-12. PubMed ID: 2893264
[TBL] [Abstract][Full Text] [Related]
18. Internalization and down-regulation of mu opioid receptors by endomorphins and morphine in SH-SY5Y human neuroblastoma cells.
Horner KA; Zadina JE
Brain Res; 2004 Dec; 1028(2):121-32. PubMed ID: 15527737
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine phosphorylation of a 58 kDa protein induced by morphine in SK-N-SH cells.
Nakano K; Osugi T; Kuo CH; Higuchi H; Miki N
Biochem Biophys Res Commun; 1994 Apr; 200(2):797-801. PubMed ID: 8179614
[TBL] [Abstract][Full Text] [Related]
20. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]